Beyond Drainage: Clinical–Ultrasound Correlation Supports a Broader Definition of the Active Tunnel in Hidradenitis Suppurativa

• by Antonio Martorell, Francisco Javier Melgosa Ramos, Pedro Navarro Guillamón

• June 18, 2026

FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa

Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.

• by Kathryn Wighton

• March 13, 2026

• 2 min

Is hidradenitis suppurativa more an autoinfection than pure autoinflammation?

• by Maïa Delage, Olivier Join-Lambert, Snaigune Miskinyte, Alain Hovnanian, Aude Nassif

• July 6, 2026

Examining TikTok's Influence on Hidradenitis Suppurativa Education Among Individuals with Skin of Color: A Cross-Sectional Study

• by Arsema K Zadu, Jordan Young, Janyla A Seltzer, Angel S Byrd, Cheri Frey

• February 27, 2026